| Financial Year |
March 31 2023 |
| Monetary Funds |
1,360,956,813.82 |
| Held-for-trading Financial Assets |
151,215,262.35 |
| Notes Receivable |
240,751,682.20 |
| Accounts Receivable |
1,589,335,483.70 |
| Advances to Suppliers |
62,789,853.69 |
| Other Receivables |
56,339,524.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
732,630.00 |
| Dividend Receivable |
2,471,100.00 |
| Inventories |
761,113,209.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
150,395,572.51 |
| Other Current Assets |
51,786,297.56 |
| Total Current Assets |
4,601,306,900.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
94,319,608.19 |
| Long-term Equity Investment |
304,342,245.22 |
| Investment Properties |
27,775,585.18 |
| Fixed Assetes |
928,154,232.00 |
| Under-construction Projects |
274,403,501.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
262,293,997.54 |
| R&D expenses |
36,535,696.03 |
| Goodwill |
844,789,448.42 |
| Long-Term Deferred and Prepaid Expenses |
51,597,682.19 |
| Deferred Income Tax Assets |
105,993,054.65 |
| Other Non-Current Assets |
261,104,988.12 |
| Sub-Total of Non-Current Assets |
4,498,145,808.13 |
| Total Assets |
9,099,452,708.84 |
| Short-Term Loans |
235,207,930.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
336,462,265.64 |
| Accounts Payable |
1,347,943,054.10 |
| Accounts Received In Advance |
8,078,615.85 |
| Employee Compensation Payable |
63,032,374.87 |
| Taxes Payable |
38,478,786.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
156,475,936.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
975,741,763.58 |
| Other Current Liabilities |
4,698,397.10 |
| Sub-Total of Current Liabilities |
3,229,797,127.22 |
| Long-term Loans |
45,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
440,466,108.14 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,832,369.11 |
| Deferred Income Tax Liabilities |
45,820,910.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
641,316,783.43 |
| Total Liabilities |
3,871,113,910.65 |
| Paid-In Capital(Or Share Stock) |
1,145,026,920.00 |
| Capital Surplus |
545,393,793.18 |
| Surplus Reserve |
551,897,543.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,612,042,657.27 |
| Minority Stockholder's Interest |
368,582,184.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,859,756,613.52 |
| Owner's Equity（Stockholder's Equity） |
5,228,338,798.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,099,452,708.84 |
